‘Yellowstone' baked beans sold in North Carolina recalled
(WKBN) – Thousands of cases of baked beans sold in nearly two dozen states are being recalled over an undeclared ingredient, according to a recall announcement published by the Food and Drug Administration.
Vietti Food Group of Nashville, Tennessee, is recalling 4,515 cases of its brown sugar molasses baked beans sold under the 'Yellowstone' brand, after the hit television series, due to the presence of undeclared soy.
WeightWatchers files for bankruptcy to eliminate over $1 billion in debt
The recall announcement warns that people with an allergy or severe sensitivity to soy risk serious or life-threatening allergic reactions if they consume the beans.
Impacted products can be identified by its best-if-used-by date of Feb. 17, 2028, according to the notice. The code is printed on the bottom of each can of beans. An image of the label can be seen below:
The label of Yellowstone Brown Sugar Molasses Baked Beans that has been recalled. (FDA)
The beans were sold in Arizona, Colorado, Delaware, Florida, Georgia, Illinois, Iowa, Kansas, Kentucky, Louisiana, Michigan, Mississippi, Missouri, New Hampshire, New York, North Carolina, Ohio, Oregon, Pennsylvania, Tennessee, Texas, Utah, and Virginia.
No illnesses or adverse reactions have been reported because of the beans, Vietti says.
If you have any of the recalled baked beans, you are being asked to return them to the place of purchase for a full refund. For questions, customers may contact Vietti Food Group at (513) 682-2474 Monday-Friday from 8:00 a.m. to 4:00 p.m. CT or email recall@zwanfood.com.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
For the latest news, weather, sports, and streaming video, head to Queen City News.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
10 hours ago
- Yahoo
Merck Gets FDA Approval to Expand Use of Its Top-Selling Drug, Keytruda
Merck has received approval from the Food and Drug Administration to expand use of its blockbuster drug, Keytruda, to treat head and neck cancers. Studies found patients taking Keytruda can reduce the risk of head and neck cancer recurrence, progression, or death by 30% compared to current treatments. Keytruda is Merck's best-selling drug, generating more than $7 billion in revenue in the first (MRK) has received the go-ahead to expand use of its blockbuster cancer drug, Keytruda. The Food and Drug Administration (FDA) has approved Keytruda's use for adults with resectable locally advanced head and neck squamous cell carcinoma whose tumors express the protein PD-L1. The study's overall principal investigator, Dr. Ravindra Uppaluri, said the approval "represents a potentially significant shift in how we manage this disease." Dr. Uppaluri added Keytruda "has been shown to reduce the risk of recurrence, progression, or death by 30%, compared with standard of care adjuvant chemoradiotherapy or radiotherapy alone." Merck noted that it's estimated that in 2025, there will be approximately 72,680 new cases of head and neck cancer diagnosed, and more than 16,680 deaths from the disease. Keytruda is the company's best-selling drug, with first-quarter revenue of $7.2 billion, making up nearly half of its total sales. Entering Friday trading, shares of Merck were down about 18% year-to-date. Read the original article on Investopedia Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Epoch Times
11 hours ago
- Epoch Times
FDA Approves Moderna's RSV Vaccine for Some Younger Adults, Company Says
Federal regulators approved Moderna's vaccine against Respiratory Syncytial Virus (RSV) for some adults as young as 18, the company said on June 12. The Food and Drug Administration (FDA) expanded approval of the shot to people aged 18 to 59 who face an increased risk from RSV, a virus that typically causes cold-like symptoms, Moderna
Yahoo
a day ago
- Yahoo
High bacteria levels detected at local beach
BAZETTA, Ohio (WKBN) — A contamination advisory has been issued for a local beach. Read only: Man sentenced to prison for threatening police officer The beach at Mosquito Lake State Park was found to have high bacteria levels, according to an alert issued Thursday afternoon. The last time high E. coli levels were detected at that beach was last August. The latest advisory will remain posted until a follow-up sample is below the recreational standard. The state's website will have any updates. Children, the elderly, and those in ill health or weakened immune systems are advised not to swim. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
